Prostate-specific Membrane Antigen Radioguidance for Salvage Lymph Node Dissection in Recurrent Prostate Cancer
Beteiligte Einrichtungen
Abstract
Prostate-specific membrane antigen (PSMA)-based radioguidance for salvage lymph node dissection (sLND) in recurrent prostate cancer has shown promising early oncological outcomes. However, long-term outcomes are still undetermined. Future studies are needed before introducing PSMA positron emission tomography-based sLND into routine clinical practice outside of clinical trials or registries.
Bibliografische Daten
| Originalsprache | Englisch |
|---|---|
| ISSN | 2405-4569 |
| DOIs | |
| Status | Veröffentlicht - 03.2021 |
Anmerkungen des Dekanats
Copyright © 2021 European Association of Urology. Published by Elsevier B.V. All rights reserved.
| PubMed | 33558200 |
|---|
